Paxlovid does not increase risk of COVID reinfection: study

Published Date: 16 Feb 2023

Although there are concerns that the use of Paxlovid increases the risk of COVID-19 returning, the results are clear.

Read Full News

Latest News

BMI in HFpEF: Friend or Foe?

A commentary on the so-called obesity paradox in Heart failure with preserved ejection fraction.

Can DBS Curb Severe Self-Injury in Autism?

A small pilot suggests deep brain stimulation may reshape dysfunctional brain circuits to curb severe self-harming behavior in children with autism.

Loneliness Linked to Lower Memory Scores, Not Faster Decline

In a 6-year study of 10,000 older adults, loneliness was tied to lower memory scores at baseline — but not to a faster rate of decline over time.

New Model Predicts HCC Risk After Hepatitis B Seroclearance

A model with six independent variables predicts the risk for hepatocellular carcinoma after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B.

Rapid Methadone Boost Tied to Better Fentanyl Use Outcomes

A methadone increase in the first 6 days of treatment is linked with better retention and lower opioid toxicity, data indicate.

Does Marital Status Affect Cancer Risk?

A large population-based study found marital status was associated with differences in cancer risk across multiple cancer types.

Todays Updates

Where Does Mistletoe Extract Fit in Supportive Cancer Care?

Mistletoe therapy may improve the QOL of patients with cancer; however, evidence does not support a survival benefit, limiting its role in routine oncology care.

A Chemo-Free Option for Some Advanced Endometrial Cancers?

A phase 2 study suggests that immunotherapy plus radiation could spare some patients with advanced endometrial cancer from chemotherapy.

Todays Updates

Where Does Mistletoe Extract Fit in Supportive Cancer Care?

Mistletoe therapy may improve the QOL of patients with cancer; however, evidence does not support a survival benefit, limiting its role in routine oncology care.

A Chemo-Free Option for Some Advanced Endometrial Cancers?

A phase 2 study suggests that immunotherapy plus radiation could spare some patients with advanced endometrial cancer from chemotherapy.

Latest News

A commentary on the so-called obesity paradox in Heart failure with preserved ejection fraction.

A small pilot suggests deep brain stimulation may reshape dysfunctional brain circuits to curb severe self-harming behavior in children with autism.

In a 6-year study of 10,000 older adults, loneliness was tied to lower memory scores at baseline — but not to a faster rate of decline over time.

A model with six independent variables predicts the risk for hepatocellular carcinoma after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B.

A methadone increase in the first 6 days of treatment is linked with better retention and lower opioid toxicity, data indicate.

A large population-based study found marital status was associated with differences in cancer risk across multiple cancer types.

News All Time

Reusable Catheters Just as Safe as Disposables

Reusable catheter strategies may be as safe as single-use devices for preventing UTIs, but questions remain about their practical use.

A Simple Test Could Predict a Patient’s Final 24 Hours

New research suggests the loss of the corneal reflex — a classic marker of brain death — could help clinicians make more specific assessments during the final days and hours of life.

Multidose Ibuprofen Regimen Eases IUD Insertion Pain

Taking three doses of ibuprofen before the insertion of an intrauterine device reduces pain during the procedure compared with a placebo.

Can AI Fix the Mental Health Crisis?

Demand is outpacing care. AI tools are already filling the gap. But are they safe, effective, and ready for clinical practice?

US Teen Depression Drops, But Disparities Persist

Major depressive episodes among US adolescents decreased significantly from 2021 to 2024, a new study shows — but disparities persist, especially between girls and boys.

Antipsychotic Stoppage During Pregnancy May Up Relapse Risk

Discontinuation of antipsychotics during pregnancy is linked to a 60% increased risk for relapse in women with primary psychotic disorders, a new study shows.

Red Blood Cell Transfusion Benefits Patients With Babesiosis

Procedure significantly improved outcomes in those hospitalized with severe disease.

MS Risk Upped Significantly With EBV Mononucleosis

Epstein-Barr virus-positive infectious mononucleosis (EBV-mono) is associated with a threefold higher multiple sclerosis risk than not having EBV-mono, new research shows.

CAR T-Cell Therapy Tied to Better Survival in Relapsed LBCL

A single-center real-world study compares the effectiveness and toxicity of chimeric antigen receptor T-cell therapy vs historical care for relapsed or refractory LBCL.

Medical Use of Cannabis Poses Risks in Adolescents

Adolescents who use cannabis on a medical recommendation report more frequent use of cannabis and other substances than peers who use the drug without a medical recommendation.

AI Chatbot Prescribing Psychiatric Meds Raises Red Flags

A pilot program that will allow a chatbot to authorize select psychiatric prescription refills while state regulators suspend enforcement of some licensure rules is raising legal and safety concerns.

AI and Medical Errors: Who Takes the Blame Now?

AI use in clinical care raises unresolved liability questions, with clinicians retaining responsibility as evolving technology and legal frameworks continue to blur accountability.

TB Today: Short-Course, Long Problems

Antibiotics transform TB care, but without stable health systems, housing improvements, and poverty reduction, the disease persists — medicine alone cannot end TB.

PrEP Use ‘Strikingly Low’ in People Younger Than 25

More training may be needed for health professionals, including pediatricians, to increase prescribing to teens.

Is the Viral Plastic Diet Linked to Eating Disorder Risk?

A viral plastic diet trend raises concerns for choking, metabolic disruption, and increased risk for eating disorders among youth.

How the Gulf Crisis Is Reaching Europe’s Pharmacies

Conflict in the Gulf is exposing how dependent Europe’s pharmacies are on global supply chains for essential medicines, active ingredients, and transport.

Recommended News For You

Sydney researchers identify new tools to improve cancer diagnosis and treatment.

Research finds low uptake of supportive care at the end-of-life for patients with advanced cancer

Have the Harms of Lung Cancer Screening Been Exaggerated?

FINAL USPSTF RECOMMENDATIONS ON ANXIETY, DEPRESSION, AND SUIICIDAL RISK.

Scientists are investigating the prevention of recurrent breast cancer, which frequently results in death.

Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer

Error on the MGUS-Autoimmune Disease Association.

Recommended Articles For You

Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians 

A Revolutionary Guide to Calculating Absolute Neutrophil Counts 

ERASur: Evaluating Total Ablative Therapy in Limited Metastatic Colorectal Cancer 

Unraveling the Genetic Mystery of Hereditary Spherocytosis 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

"Unusual" Cancers Following Pandemic; Triumph in TNBC; Clinical Trial Interrupted by Shortage.

2.

Scientists Employ Technology to Identify Plagiarism and Forgeries in Published Studies.

3.

COVID Lockdowns Significantly Increasing Children's Vitamin D Deficiency?

4.

For the treatment of vestibular schwannomas in neurofibromatosis type 2, stereotactic radiosurgery has been found to be effective.

5.

Why are so many young adults getting cancer?

1.

The Benefits and Risks of Cervical Conization

2.

Demystifying Hematoma Rectus Sheath: Knowing the Symptoms and Causes

3.

Sorafenib: Understanding the science behind a powerful cancer drug 

4.

Impact of Hormone Therapy Cessation on Tumor Growth: Case Study of Ki-67 Reduction

5.

The Oncologist’s Edge: Tools, Trials, and Tech Transforming Treatment

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites

2.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

3.

Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care

4.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI

5.

From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot